Search research articles
Contact Us
Filters
Showing results (131-140 of 182) with videos related to
Page
of 19
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Nature Communications
|
November 15, 2024
VSV<sup>∆M51</sup> drives CD8<sup>+</sup> T cell-mediated tumour regression through infection of both cancer and non-cancer cells
Jahanara Rajwani, Daniil Vishnevskiy, Madison Turk, et al.
The New England Journal of Medicine
|
September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Jennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Neuro-Oncology
|
April 1, 2015
Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype
Guillaume Bergthold, Pratiti Bandopadhayay, Yujin Hoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano, Alessandra Fucci, Veronique Frattini, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Plos One
|
August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
Alice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Journal of the National Cancer Institute
|
May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
Simron Singh, Thomas A Hope, Emily B Bergsland, et al.
Page
of 19
Search research articles
Search
Showing results (131-140 of 182) with videos related to
Sort By:
Page
of 19
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.
Nature Communications
|
November 15, 2024
VSV<sup>∆M51</sup> drives CD8<sup>+</sup> T cell-mediated tumour regression through infection of both cancer and non-cancer cells
Jahanara Rajwani, Daniil Vishnevskiy, Madison Turk, et al.
The New England Journal of Medicine
|
September 16, 2024
Phase 3 Trial of Cabozantinib to Treat Advanced Neuroendocrine Tumors
Jennifer A Chan, Susan Geyer, Tyler Zemla, et al.
Neuro-Oncology
|
April 1, 2015
Expression profiles of 151 pediatric low-grade gliomas reveal molecular differences associated with location and histological subtype
Guillaume Bergthold, Pratiti Bandopadhayay, Yujin Hoshida, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 23, 2015
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano, Alessandra Fucci, Veronique Frattini, et al.
Cancer
|
March 27, 2019
FOLFOX plus ziv-aflibercept or placebo in first-line metastatic esophagogastric adenocarcinoma: A double-blind, randomized, multicenter phase 2 trial
James M Cleary, Nora K Horick, Nadine Jackson McCleary, et al.
Nature Communications
|
August 9, 2024
Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma
Harshabad Singh, Kristen E Lowder, Kevin Kapner, et al.
Plos One
|
August 29, 2018
ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts
Alice L Yuan, Christian B Ricks, Alexandra K Bohm, et al.
Cancer Research
|
June 25, 2009
Evaluation of the 8q24 prostate cancer risk locus and MYC expression
Mark M Pomerantz, Christine A Beckwith, Meredith M Regan, et al.
Journal of the National Cancer Institute
|
May 31, 2023
Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting
Simron Singh, Thomas A Hope, Emily B Bergsland, et al.
Page
of 19